Results 1 to 5 of 5

Thread: Ketamine-like Drug Product Fails trial, Is One Step Closer to FDA Approval

  1. #1
    Veteran Member
    Join Date
    14th July 2010
    Posts
    1,417

    Default Ketamine-like Drug Product Fails trial, Is One Step Closer to FDA Approval

    [According to Wikipedia, “Esketamine, sold under the brand names Ketanest among others,[2][3][4][5] is a general anesthetic and a dissociative hallucinogen.[1] It is the S(+) enantiomer of ketamine, which is an anesthetic and dissociative similarly.[1]”]

    J&J's esketamine nasal spray flunks late-stage study in treatment-resistant depression

    Sep. 24, 2018
    Douglas W. House, SA News Editor

    A Phase 3 clinical trial evaluating two dose strengths (56 mg and 84 mg) of Johnson & Johnson (JNJ -0.9%) unit Janssen Pharmaceutical's esketamine nasal spray in patients with treatment-resistant depression failed to demonstrate a statistically valid treatment effect compared to placebo.

    https://seekingalpha.com/news/3392427-j-and-js-esketamine-nasal-spray-flunks-late-stage-study-treatment-resistant-depression

    So how did THIS happen?

    FDA Ad Com backs J&J's esketamine nasal spray antidepressant

    Feb. 12, 2019
    Douglas W. House, SA News Editor

    The FDA advisory committees voted 14 - 2 (1 abstain) in favor that Johnson & Johnson's (JNJ +1.5%) Janssen Pharmaceuticals provided sufficient evidence to support the effectiveness of its esketamine nasal spray for treatment-resistant depression.

    Update: The vote was 15 - 2 in favor of the safety profile.
    Update: The vote was 14 - 2 (1 abstain) that the benefits outweigh the risks.

    https://seekingalpha.com/news/343230...antidepressant

    [Note: Apparently Johnson and Johnson plans to call the nasal spray “Spravato” if it is ultimately approved.]

  2. #2
    Administrator Islander's Avatar
    Join Date
    16th September 2007
    Location
    Maine, USA. The way life should be.
    Posts
    17,694

    Default Re: Ketamine-like Drug Product Fails trial, Is One Step Closer to FDA Approval

    Did anyone notice that yesterday's media all broke the same story, in excited tones, with barely contained enthusiasm? There was just one little problem: every one of the MSM claimed that the FDA has approved this miracle drug for depression… Except for the New York Times, which specifically said, "The cost for these treatments typically is out of pocket, as the generic anesthetic is not approved by the F.D.A. for depression." See for yourself: https://www.nytimes.com/2019/03/05/h...amine-fda.html
    ➤ Happiness is the frosting on the cake of contentment.

  3. #3
    Veteran Member
    Join Date
    14th July 2010
    Posts
    1,417

    Default Re: Ketamine-like Drug Product Fails trial, Is One Step Closer to FDA Approval

    The NYT also says that the FDA has approved Janssen's new drug: "On Tuesday, the Food and Drug Administration approved a prescription treatment intended to help them, a fast-acting drug derived from an old and widely used anesthetic, ketamine."

    The treatment referred to in the sentence you cited is generic ketamine, which is an anesthetic, when it is used for depression:

    "The cost for these treatments [this refers NOT to esketamine and this new product, but to ketamine itself, which is a generic anesthetic also used for depression in some clinics, as explained in the previous paragraph] typically is out of pocket, as the generic anesthetic is not approved by the F.D.A. for depression. In contrast, esketamine likely would be covered under many insurance plans, and its side effects, though similar to those of generic ketamine, are thought to be less dramatic."

    It might have been clearer if the author had used “those” treatments instead of “this,” or perhaps just worded it differently.

  4. #4
    Veteran Member
    Join Date
    14th July 2010
    Posts
    1,417

    Default Re: Ketamine-like Drug Product Fails trial, Is One Step Closer to FDA Approval

    Also important to note, I think, is this, from the same NYT article:

    "Historically, the F.D.A. has required that a drug succeed in two short-term trials before it is approved; the agency loosened its criteria for esketamine, opting instead to study relapse in people who did well on the drug." (Emphasis added)

  5. #5
    Administrator Islander's Avatar
    Join Date
    16th September 2007
    Location
    Maine, USA. The way life should be.
    Posts
    17,694

    Default Re: Ketamine-like Drug Product Fails trial, Is One Step Closer to FDA Approval

    Well that explains your earlier question about how, despite the drug's failure to demonstrate reliable effects, its approval was moved forward anyway. Well, that plus dollars. Janssen will make bank on the staggering cost of the treatment — which is based on a cheap black-market club drug!
    ➤ Happiness is the frosting on the cake of contentment.

Thread Information

Users Browsing this Thread

There are currently 1 users browsing this thread. (0 members and 1 guests)

Similar Threads

  1. Replies: 1
    Last Post: 02-14-19, 12:54 PM
  2. Replies: 2
    Last Post: 09-23-17, 08:17 PM
  3. Coeliac Vaccine One Step Closer
    By LabDoc in forum Vaccines
    Replies: 4
    Last Post: 05-17-11, 08:30 PM
  4. FDA holds up approval of Alexza's anti-psychotic drug
    By Islander in forum Prescription Medications
    Replies: 0
    Last Post: 10-13-10, 01:50 PM
  5. Replies: 0
    Last Post: 07-28-10, 10:52 AM

Tags for this Thread

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •  
<<<<<<<< Your Customized Value <<<<<<<<